COMPARISON OF VISUAL AND QUANTITATIVE ASSESSMENT FOR FDG-PET INTERPRETATION IN HODGKIN LYMPHOMA AFTER 2 CYCLES OF ABVD. THE EORTC-GELA-IIL H10 TRIAL EXPERIENCE

被引：0
|
作者：
Jullian, A. [1 ]
Meignan, M. [1 ]
Itti, E. [1 ]
Bardet, S. [1 ]
Edeline, V [1 ]
Vanderborght, T. [1 ]
Reman, O. [1 ]
Ricci, R. [1 ]
Brusamolino, E. [1 ]
Raemaekers, J. M. M. [1 ]
Andre, M. [1 ]
机构：
[1] CHU Toulouse, Dept Nucl Med, Toulouse, France
来源：
HAEMATOLOGICA | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P163
引用
收藏
页码：S49 / S49
页数：1
相关论文
共 14 条
  • [1] POSITIVE INTERIM PET AFTER 2 ABVD IS MORE FREQUENT IN PATIENTS WITH UNFAVOURABLE STAGE I/II HODGKIN LYMPHOMA AND BULKY MEDIASTINUM THAN IN NON-BULKY. THE EORTC-GELA-IIL H10 TRIAL EXPERIENCE. THE EORTC-GELA-IIL H10 TRIAL EXPERIENCE
    Yeddes, I
    Meignan, M.
    Bardet, S.
    Vander Borght, T.
    Ricci, R.
    Itti, E.
    Lumbroso, J.
    Edeline, V
    Olivier, P.
    Borght, T., V
    Reman, O.
    Karcher, G.
    Mundler, O.
    Hutchings, M.
    Versari, A.
    Bellei, M.
    Raemaekers, J. M. M.
    Andre, M.
    HAEMATOLOGICA, 2010, 95 : S49 - S49
  • [2] Single institution preliminary experience on dose reduction to organs at risk in thoracic radiotherapy for patients enrolled in EORTC-GELA-IIL H10 study protocol on early stage Hodgkin's Lymphoma
    Filippi, A. R.
    Ciammella, P.
    Namsyl-Kaletka, A.
    Botticella, A.
    Todisco, L.
    Fiandra, C.
    Ragona, R.
    Vitola, U.
    Ricardi, U.
    EJC SUPPLEMENTS, 2009, 7 (02): : 158 - 159
  • [3] The H10 EORTC/GELA randomized intergroup trial on early FDG-PET scan guided treatment adaptation versus standard combined modality treatment in patients with supradiaphragmatic stage I/II Hodgkin's lymphoma
    Andre, M.
    Raemaekers, J.
    Van der Maazen, R.
    Reman, O.
    Van't Veer, M.
    Lutgenburg, E.
    Girinski, T.
    Ferme, C.
    Brice, P.
    Casasnovas, O.
    Meignan, M.
    Auduin, J.
    Bosq, J.
    Mounier, N.
    Van Glabekke, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 7 - 7
  • [4] First Report On the H10 EORTC/GELA/IIL Randomized Intergroup Trial On Early FDG-PET Scan Guided Treatment Adaptation Versus Standard Combined Modality Treatment in Patients with Supra-Diaphragmatic Stage I/H Hodgkin's Lymphoma, for the Groupe d'Etude Des Lymphomes De l'Adulte (GELA), European Organisation for the Research and Treatment of Cancer (EORTC) Lymphoma Group and the Intergruppo Italiano Linfomi (IIL).
    Andre, Marc P. E.
    Reman, Oumedaly
    Federico, Massimo
    Brice, Pauline
    Brusamolino, Ercole
    Girinski, Theodore
    Ferme, Christophe
    vander Maazen, Richard
    Bellei, Monica
    Sebban, Catherine
    Morschhauser, Franck
    Lugtenburg, Elly
    Stamatoullas, Aspasia
    Baila, Liliana
    Fortpied, Catherine
    Meignan, Michel
    Raemaekers, John M.
    BLOOD, 2009, 114 (22) : 44 - 45
  • [5] RAPID Trial Demonstrates Low Positive Predictive Value of Interim FDG-PET in Early-stage Hodgkin Lymphoma After Three Cycles of ABVD
    Fulbright, Joy M.
    Williams, Sarah E.
    Pahud, Barbara A.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2016, 38 (02) : 165 - 165
  • [6] Early FDG-PET Adapted Treatment Improves the Outcome of Early FDG-PET-Positive Patients With Stages I/II Hodgkin Lymphoma (HL): Final Results of the Randomized Intergroup EORTC/LYSA/FIL H10 Trial
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (08) : 16 - 17
  • [7] Prognostic Value of Baseline Quantitative PET Metrics for Patients with Unfavourable Early Stage Hodgkin Lymphoma Enrolled in the Standard Arm of the EORTC/Lysa/FIL H10 Trial
    Cottereau, Anne Segolene
    Versari, Annibale
    Loft, Annika
    Casasnovas, Rene-Olivier
    Bellei, Monica
    Ricci, Romain
    Bardet, Stephane
    Castagnoli, Antonio
    Brice, Pauline
    Raemaeker, John
    Itti, Emmanuel
    Forpied, Catherine
    Raveloarivahy, Tiana
    Girinsky, Theodore
    Van der Borght, Thierry
    Federico, Massimo
    Hutchings, Martin
    Ricardi, Umberto
    Meignan, Michel
    Andre, Marc
    BLOOD, 2016, 128 (22)
  • [8] Relapse patterns in early-PET negative, limited-stage Hodgkin lymphoma (HL) after ABVD with or without radiotherapy-a joint analysis of EORTC/LYSA/FIL H10 and NCRI RAPID trials
    Fiaccadori, Valeria
    Neven, Anouk
    Fortpied, Catherine
    Aurer, Igor
    Andre, Marc
    Federico, Massimo
    Counsell, Nicholas
    Phillips, Elizabeth H.
    Clifton-Hadley, Laura
    Barrington, Sally F.
    Illidge, Timothy
    Radford, John
    Raemaekers, John M. M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 200 (06) : 731 - 739
  • [9] FDG-PET for assessment of residual tissue after completion of chemotherapy in hodgkin lymphoma-2nd interim analysis of the PET investigation in the trial HD15 of the German Hodgkin Study Group (GHSG)
    Kobe, C.
    Dietlein, M.
    Franklin, J.
    Eich, H.
    Fuchs, M.
    Gossmann, A.
    Pfistner, B.
    Schicha, H.
    Amthauer, H.
    Brenner, W.
    Dierlamm, J.
    Bockisch, A.
    Knapp, W.
    Weckesser, M.
    Lorenz, R.
    Sabri, O.
    Scheidhauer, K.
    Tiling, R.
    Haberkorn, U.
    Gruenwald, F.
    Schreckenberger, M.
    Sciuk, J.
    Bares, R.
    Marienhagen, J.
    Kirsch, C. -M.
    Diehl, V.
    Engert, A.
    ONKOLOGIE, 2008, 31 : 132 - 133
  • [10] FDG-PET FOR ASSESSMENT OF RESIDUAL TISSUE AFTER COMPLETION OF CHEMOTHERAPY IN HODGKIN LYMPHOMA REPORT ON THE 2ND INTERIM ANALYSIS OF THE PET INVESTIGATION IN THE TRIAL HD15 OF THE GHSG
    Fuchs, M.
    Haverkamp, H.
    Dietlein, M.
    Diehl, V.
    Engert, A.
    Kobe, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 190 - 190
12